Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,601,062 papers from all fields of science
Search
Sign In
Create Free Account
THERATOPE
Known as:
THERATOPE STn-KLH vaccine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
cyclophosphamide/THERATOPE STn-KLH vaccine
sialyl-Tn antigen-keyhole-limpet hemocyanin conjugate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Clinical outcome of breast and ovarian cancer patients treated after high-dose chemotherapy and autologous stem cell rescue with theratope (STn-KLH) cancer vaccine theratope (STn-KLH) cancer vaccine…
L. Holmberg
,
K. Guthrie
,
B. Sandmaier
2008
Corpus ID: 79106120
The success of autologous peripheral blood stem cell transplantation (ASCT) as treatment for breast and ovarian cancer is limited…
Expand
2005
2005
Current and future perspectives on fulvestrant.
W. Gradishar
,
T. Sahmoud
Clinical Breast Cancer
2005
Corpus ID: 24767141
Fulvestrant, an estrogen receptor antagonist with no known agonist effects, is effective and well tolerated in the treatment of…
Expand
2004
2004
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2004
Corpus ID: 36014232
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2003
2003
The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).
L. Holmberg
,
D. V. Oparin
,
T. Gooley
,
B. Sandmaier
Clinical Breast Cancer
2003
Corpus ID: 30255855
The success of high-dose chemotherapy followed by autologous stem-cell rescue as treatment for breast and ovarian cancer is…
Expand
Review
2003
Review
2003
Cancer Vaccine THERATOPE® — Biomira
Adis Editorial
Drugs in R&D
2003
Corpus ID: 8217897
Biomira is developing a therapeutic cancer vaccine [THERATOPE®] for treatment of breast and other cancers.1 THERATOPE® consists…
Expand
Review
2000
Review
2000
Technology evaluation: Theratope, Biomira Inc.
Michael A. Morse
Current opinion in molecular therapeutics (Print)
2000
Corpus ID: 39168794
Active specific immunotherapy, the use of 'vaccines' to stimulate therapeutic tumor antigen-specific immune responses, holds…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE